Advisory Board

Amanda Finck, PhD - University of Pennsylvania

Dr. Amanda Finck, Ph.D., is the Director of Translational Research for RVCL at the University of Pennsylvania. Dr. Finck earned her doctorate under Dr. Carl June at the Center for Cellular Immunotherapies and has built deep expertise across both academic and industry settings, with research spanning CAR T cell biology, single-cell transcriptomics and proteomics, and bispecific antibody platforms for hematologic malignancies through work at UPenn, Yale, and Janssen Pharmaceuticals. With over a decade of research experience complemented by active involvement in biotech innovation, including roles with Flagship Pioneering, Penn Center for Innovation, Penn Biotech Group, and Interlink Markets, she brings a combination of scientific rigor and translational perspective. Dr. Finck believes that bridging cutting-edge immunology with strategic drug development will be critical to delivering successful treatments for patients with RVCL.